[Aggregation inhibitors for treatment of the acute phase of cerebral ischemia].
Platelets are decisive factors leading to establishing brain ischaemia. Additional growth of their activity is to be found in the early stage of the disease. It is a result of the changes in neurons and endothelium of the ischaemic area. That is the reason why there is attention given to the necessity of the application of the aggregation inhibitor drugs in the first days since the symptoms of the disease have appeared. Even that the aggregation inhibitor drugs constitute the majority of the drug kind only few of them have been successfully used in the therapy of the brain ischaemia.
Szczepańska-Szerej
A
A
Katedra i Klinika Neurologii, Akademia Medyczna w Lublinie.
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors